Nath Bio-Genes (India) Limited (NATHBIOGEN) — Board Meeting | 29 July 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approved Q1 FY26 results and scheduled AGM for 24 September 2026

The Board approved the Q1 FY26 unaudited standalone and consolidated financial results and set the 24 September 2026 date for the 33rd Annual General Meeting, with procedures to be disclosed later.

📄 View Original Announcement (PDF)

About Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹289.43 Cr P/E: 7.8 ROE: 6.0% ROCE: 7.9% Div Yield: 1.31%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day